Zobrazeno 1 - 10
of 146
pro vyhledávání: '"Robert L, Souhami"'
Autor:
Helena M. Earl, Sean Connolly, Christos Latoufis, Karen Eagle, Catherine M. Ash, Clare Fowler, Robert L. Souhami
Publikováno v:
Sarcoma, Vol 2, Iss 2, Pp 97-105 (1998)
Purpose. To study the long-term neurotoxicity of chemotherapy in adolescents and young adults treated for bone and soft tissue sarcomas.
Externí odkaz:
https://doaj.org/article/9fcebed7ef5a4098ba145b48a9e2c7fa
Autor:
Vivien H. C. Bramwell, Marion V. Burgers, Robert L. Souhami, Antonie H. M. Taminiau, Jan W. Van Der Eijken, Alan W. Craft, Archie J. Malcolm, Barbara Uscinska, Anna L. Kirkpatrick, David Machin, Martine M. Van Glabbeke
Publikováno v:
Sarcoma, Vol 1, Iss 3-4, Pp 155-160 (1997)
Purpose. To report the outcome of 37 patients with metastatic osteosarcoma entered into a large randomized trial (EOI 80831/MRC B002) comparing two different regimens of chemotherapy in patients with osteosarcoma.
Externí odkaz:
https://doaj.org/article/0ea601920e044d65a418769442b52a1d
Publikováno v:
Sarcoma, Vol 1, Iss 3-4, Pp 183-187 (1997)
A multi-focal multi-centric, malignant tumour of vascular origin arising in bone in a 55-year-old man is described. The presenting symptoms were pain and weight loss. Radiologically, multiple lytic lesions were demonstrated in the long bones of both
Externí odkaz:
https://doaj.org/article/1cc9e5021e2b4efdb53a49852d333d53
Autor:
M Griffiths, Fiona M. Moss, Mary N. Sheppard, Lynda G. Bobrow, Peter C. L. Beverley, Bruce J. Addis, Robert L. Souhami, Deborah Rowe
Seventy-one lung carcinomas from 66 different patients were stained with a panel of monoclonal antibodies. Twenty-nine were small cell lung carcinoma (SCLC), 15 adenocarcinomas, 17 squamous carcinomas and 10 large cell carcinomas. Three of the monocl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40af6b1dca1fdd19a5def8caf692d23b
https://doi.org/10.1002/path.1711490205
https://doi.org/10.1002/path.1711490205
We have studied the reactivity profile of the small cell lung cancer (SCLC) workshop monoclonal antibodies (Moabs) using SCLC, neuroblastoma, rhabdomyosarcoma and epithelial cell lines, applying the indirect immunoperoxidase technique on cytospin pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85f2633b9240a2e24bab94181e4064bc
https://ora.ox.ac.uk/objects/uuid:73ba17e2-35b7-4a3b-a826-dedd4b611396
https://ora.ox.ac.uk/objects/uuid:73ba17e2-35b7-4a3b-a826-dedd4b611396
Autor:
Mahesh K. B. Parmar, David Spiegelhalter, Douglas G. Altman, Gareth Griffiths, Robert L. Souhami, Emmanuel van der Scheuren
BACKGROUND: In judging whether or not to continue enrolling patients into a randomised clinical trial, most data-monitoring and ethics committees (DMECs) rely on the p value for the difference in effect between the study groups. In the 1990s, two ran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06e4418aeefe0414e1d70aaf546ffce9
https://doi.org/10.1016/s0140-6736(01)05558-1
https://doi.org/10.1016/s0140-6736(01)05558-1
We selected a group of 18 monoclonal antibodies (Moabs) from the panel submitted for study in the Workshop and have studied their cross-blocking reactivity and pattern of immunofluorescence staining using small cell lung cancer (SCLC) and small round
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3c366a63c4ed70a8af3782d896b113b
https://doi.org/10.1016/s0169-5002(88)80031-x
https://doi.org/10.1016/s0169-5002(88)80031-x